Bank of New York Mellon’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-65,734
| Closed | -$76K | – | 4653 |
|
|
2022
Q2 | $76K | Sell |
65,734
-155,564
| -70% | -$163K | ﹤0.01% | 4287 |
|
|
2022
Q1 | $239K | Sell |
221,298
-1
| -0% | -$1 | ﹤0.01% | 4153 |
|
|
2021
Q4 | $160K | Buy |
221,299
+5,425
| +3% | +$4.39K | ﹤0.01% | 4337 |
|
|
2021
Q3 | $194K | Buy |
215,874
+21,703
| +11% | +$26.1K | ﹤0.01% | 4224 |
|
|
2021
Q2 | $322K | Buy |
194,171
+56,227
| +41% | +$94K | ﹤0.01% | 3944 |
|
|
2021
Q1 | $288K | Sell |
137,944
-2,000
| -1% | -$4.15K | ﹤0.01% | 3924 |
|
|
2020
Q4 | $175K | Sell |
139,944
-8,590
| -6% | -$10.2K | ﹤0.01% | 4009 |
|
|
2020
Q3 | $181K | Buy |
148,534
+852
| +0.6% | +$1.04K | ﹤0.01% | 3867 |
|
|
2020
Q2 | $173K | Buy |
147,682
+39,939
| +37% | +$36.9K | ﹤0.01% | 3832 |
|
|
2020
Q1 | $88K | Buy |
107,743
+1
| +0% | +$1 | ﹤0.01% | 3879 |
|
|
2019
Q4 | $108K | Hold |
107,742
| – | – | ﹤0.01% | 4015 |
|
|
2019
Q3 | $152K | Sell |
107,742
-6,050
| -5% | -$8.54K | ﹤0.01% | 3962 |
|
|
2019
Q2 | $170K | Sell |
113,792
-2,022
| -2% | -$3.13K | ﹤0.01% | 3955 |
|
|
2019
Q1 | $177K | Sell |
115,814
-239
| -0.2% | -$365 | ﹤0.01% | 3912 |
|
|
2018
Q4 | $171K | Hold |
116,053
| – | – | ﹤0.01% | 3878 |
|
|
2018
Q3 | $212K | Hold |
116,053
| – | – | ﹤0.01% | 3918 |
|
|
2018
Q2 | $214K | Buy |
+116,053
| New | +$216K | ﹤0.01% | 3909 |
|
|
2016
Q3 | – | Sell |
-10,709
| Closed | -$9K | – | 4330 |
|
|
2016
Q2 | $9K | Hold |
10,709
| – | – | ﹤0.01% | 4299 |
|
|
2016
Q1 | $10K | Hold |
10,709
| – | – | ﹤0.01% | 4197 |
|
|
2015
Q4 | $12K | Hold |
10,709
| – | – | ﹤0.01% | 4302 |
|
|
2015
Q3 | $23K | Hold |
10,709
| – | – | ﹤0.01% | 4312 |
|
|
2015
Q2 | $21K | Sell |
10,709
-81,516
| -88% | -$231K | ﹤0.01% | 4222 |
|
|
2015
Q1 | $357K | Buy |
92,225
+21,201
| +30% | +$78.5K | ﹤0.01% | 3732 |
|
|
2014
Q4 | $256K | Sell |
71,024
-2,009
| -3% | -$5.32K | ﹤0.01% | 3823 |
|
|
2014
Q3 | $195K | Buy |
73,033
+7,449
| +11% | +$49.8K | ﹤0.01% | 3905 |
|
|
2014
Q2 | $762K | Buy |
65,584
+22,101
| +51% | +$250K | ﹤0.01% | 3455 |
|
|
2014
Q1 | $608K | Buy |
43,483
+24,784
| +133% | +$389K | ﹤0.01% | 3512 |
|
|
2013
Q4 | $332K | Buy |
18,699
+8,284
| +80% | +$135K | ﹤0.01% | 3719 |
|
|
2013
Q3 | $176K | Buy |
+10,415
| New | +$146K | ﹤0.01% | 3824 |
|
Bank of New York Mellon's MBII Position: Q3 2022 in Review
Bank of New York Mellon sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 65,734 shares — an estimated $76K sold.
Bank of New York Mellon first reported a position in MBII in Q3 2013 and held it in 29 quarters. The position peaked at $762K in Q2 2014. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Bank of New York Mellon reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Bank of New York Mellon sold 65,734 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $76K.
- Bank of New York Mellon first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 29 quarters.
- Bank of New York Mellon's Marrone Bio Innovations, Inc. position peaked at $762K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Bank of New York Mellon's 13F filing for Q3 2022, filed 14 Nov 2022.